PPARD and obesity due to melanocortin 4 receptor deficiency: Withpharmacological agonists and genetic manipulations of PPARδcoming to fruition in recent years, these expectations arestarting to be realized, and implicate PPARδ in importantaspects of obesity, energy metabolism and metabolic disease.